![]() |
市場調查報告書
商品編碼
2058942
菌蛋白食品市場預測至2034年-按產品類型、形態、應用、分銷管道和最終用戶分類的全球分析Mycoprotein-Based Foods Market Forecasts to 2034 - Global Analysis By Product Type, Form, Application, Distribution Channel, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球真菌蛋白食品市場規模將達到 18 億美元,並在預測期內以 11.1% 的複合年成長率成長,到 2034 年將達到 42 億美元。
菌蛋白食品是利用絲狀真菌進行可控發酵加工而成的富含蛋白質的產品。由此產生的生質能富含天然蛋白質和膳食纖維,質地類似肉類,因此適合作為肉類替代品。與畜牧業相比,菌蛋白生產所需的土地和水資源較少,是一種永續的蛋白質來源。它們被廣泛用於製作無肉產品,例如雞塊、香腸和蒸餾食品。此外,對於尋求高品質替代蛋白質和必需胺基酸的素食者和彈性素食者來說,菌蛋白食品通常被視為一種營養豐富的選擇。
對永續蛋白質來源的興趣
消費者越來越關注傳統肉品生產對環境的影響。菌蛋白是一種低碳、資源高效的替代品,深受具有環保意識的消費者的青睞。消費者對植物來源和替代蛋白的需求不斷成長,推動了菌蛋白的流行。注重健康的消費者也十分欣賞菌蛋白的高纖維和高蛋白含量。食品公司正大力宣傳其永續性舉措,以吸引年輕一代的消費者。
消費者對過敏原的擔憂
部分人群對真菌蛋白產品中使用的真菌蛋白會產生過敏反應。監管機構呼籲加強標籤標註,以消除安全隱患。媒體對過敏反應的負面報導會削弱消費者的信心。製造商面臨教育消費者安全食用方法的挑戰。消費者對過敏原風險的認知不足限制了某些地區的市場滲透。這一因素阻礙了更廣泛的市場拓展。
一種新型即食產品
快節奏的生活方式推動了人們對便利、高蛋白餐點的需求。即食產品,例如零食、冷凍食品和食材自煮包,在都市區消費者中廣受歡迎。口味和包裝的創新提升了產品的吸引力。價格親民的產品能夠吸引更多一般消費者,而不僅僅是注重健康的族群。與外送平台的合作擴大了銷售範圍。隨著便利性成為人們關注的重點,預計這一細分市場將快速成長。
與植物性蛋白質的競爭
大豆、豌豆和燕麥蛋白佔據了消費者認知的主導地位。植物蛋白品牌的強力行銷導致消費者對菌蛋白的認知度下降。在價格競爭力方面,廣泛銷售的植物蛋白具有優勢。與主流產品相比,消費者可能將菌蛋白視為小眾產品。新興蛋白品類在零售店的貨架空間往往有限。這種競爭對品牌的長期差異化構成了挑戰。
新冠疫情對菌蛋白食品市場產生了複雜的影響。一方面,隨著消費者更重視增強免疫力和永續的飲食習慣,市場需求成長。疫情封鎖期間,線上銷售管道顯著擴張。另一方面,供應鏈中斷影響了原料供應。經濟的不確定性導致部分地區高階產品的銷售下降。整體而言,疫情提高了人們對替代蛋白的認知度,並促進了菌蛋白市場的長期成長。
在預測期內,冷凍產品細分市場預計將佔據最大的市場佔有率。
隨著消費者越來越重視便利性和較長的保存期限,預計在預測期內,冷凍產品將佔據最大的市場佔有率。冷凍菌蛋白食品和肉類替代品在零售通路中廣受歡迎。便攜性和口味創新使冷凍產品深受忙碌的商務人士青睞。製造商正致力於口味多樣化,以防止消費者對口味產生厭倦。冷凍產品既能吸引彈性素食者,也能吸引一般消費者。在已開發市場,冷凍食品在零售市場的滲透率正在不斷提高。
預計在預測期內,營養產品細分市場將呈現最高的複合年成長率。
在預測期內,由於消費者對機能性食品食品和強化食品的需求不斷成長,營養產品領域預計將呈現最高的成長率。消費者為了健康管理,正在將高蛋白補充劑和代餐食品納入日常飲食中。菌蛋白中富含天然纖維和蛋白質,為其營養價值提供了有力支撐。尤其年輕一代更傾向選擇強化型健康產品。這些產品的營養益處正透過數位平台和健身宣傳活動進行推廣。
在預測期內,由於消費者意識高漲以及植物來源食品的日益普及,歐洲預計將佔據最大的市場佔有率。歐洲市場擁有完善的法規結構,為替代蛋白的創新提供了支持。許多大型企業和研究機構的總部都設在該地區。消費者的永續發展意識已根深蒂固。在英國、德國和荷蘭等國家,真菌蛋白產品在零售市場正日益受到歡迎。預防醫學和環保生活方式正在推動市場需求。歐洲將繼續成為全球整體銷售額的最大貢獻者。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於人們健康意識的不斷提高。在中國、印度和東南亞的都市區,替代蛋白的普及率正在迅速成長。電子商務平台正在協助小眾蛋白產品的分銷。文明病的增加推動了人們對均衡營養需求的成長。價格親民、即食的菌蛋白產品正受到廣大消費者的青睞。年輕一代正在積極實踐永續飲食。亞太地區將成為全球成長最快的地區。
According to Stratistics MRC, the Global Mycoprotein-Based Foods Market is accounted for $1.80 billion in 2026 and is expected to reach $4.20 billion by 2034 growing at a CAGR of 11.1% during the forecast period. Mycoprotein-based foods are protein-rich products derived from filamentous fungi through controlled fermentation processes. The resulting biomass is naturally high in protein and fiber, with a meat-like texture that makes it suitable for use in meat alternatives. Mycoprotein offers a sustainable protein source due to its low land and water requirements compared to animal farming. It is commonly used in products such as meat-free nuggets, sausages, and ready meals. Additionally, it provides essential amino acids and is often positioned as a nutritious option for vegetarian and flexitarian diets seeking high-quality alternative proteins.
Sustainable protein source awareness
Consumers are increasingly concerned about the environmental impact of traditional meat production. Mycoprotein offers a low-carbon, resource-efficient alternative that appeals to eco-conscious buyers. Growing demand for plant-based and alternative proteins supports adoption. Health-conscious consumers also value mycoprotein's high fiber and protein content. Food companies are promoting sustainability credentials to attract younger demographics.
Allergen concerns among consumers
Some individuals experience sensitivities to fungal proteins used in mycoprotein products. Regulatory bodies require clear labeling to address safety issues. Negative publicity around allergic reactions can reduce consumer confidence. Manufacturers face challenges in educating buyers about safe consumption. Limited awareness of allergen risks restricts adoption in certain regions. This factor poses a barrier to wider market penetration.
Novel ready-to-eat product formats
Busy lifestyles are driving demand for convenient protein-rich meals. Ready-to-eat options such as snacks, frozen meals, and meal kits appeal to urban consumers. Innovation in flavors and packaging enhances product appeal. Affordable offerings can attract mainstream buyers beyond niche health segments. Partnerships with food delivery platforms expand reach. This segment is expected to grow rapidly as convenience becomes a priority.
Competition from plant proteins
Soy, pea, and oat proteins dominate consumer awareness. Strong marketing by plant-based brands reduces visibility of mycoprotein. Price competitiveness favors widely available plant proteins. Consumers may perceive mycoprotein as niche compared to mainstream options. Retail shelf space is often limited for emerging protein categories. This competition creates challenges for long-term brand differentiation.
Covid-19 had a mixed impact on the mycoprotein-based foods market. On one hand, demand rose as consumers focused on immunity and sustainable diets. Online sales channels grew significantly during lockdowns. On the other hand, supply chain disruptions affected ingredient availability. Economic uncertainty limited premium purchases in some regions. Overall, the pandemic accelerated awareness of alternative proteins, supporting long-term growth.
The frozen products segment is expected to be the largest during the forecast period
The frozen products segment is expected to account for the largest market share during the forecast period as consumers increasingly prefer convenient storage and long shelf life. Frozen mycoprotein meals and meat substitutes are widely adopted in retail channels. Portability and taste innovation make frozen formats popular among busy professionals. Manufacturers are investing in flavor diversity to reduce taste fatigue. Frozen products appeal to both flexitarian and mainstream consumers. Retail penetration of frozen foods is strong in developed markets.
The nutritional products segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the nutritional products segment is predicted to witness the highest growth rate due to rising demand for functional and fortified foods. Consumers are adopting protein-rich supplements and meal replacements for health management. Mycoprotein's natural fiber and protein content supports nutritional positioning. Younger demographics are particularly inclined toward fortified wellness products. Digital platforms and fitness campaigns promote nutritional benefits.
During the forecast period, the Europe region is expected to hold the largest market share owing to strong consumer awareness and established plant-based adoption. European markets have advanced regulatory frameworks supporting alternative protein innovation. Leading companies and research institutions are headquartered in this region. Sustainability trends are well established among consumers. Retail penetration of mycoprotein products is strong in countries such as the UK, Germany, and the Netherlands. Preventive health and eco-conscious lifestyles drive demand. Europe will remain the largest contributor to global revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing health consciousness. Urban populations in China, India, and Southeast Asia are adopting alternative proteins rapidly. E-commerce platforms support distribution of niche protein products. Lifestyle-related diseases are increasing, fueling demand for balanced nutrition. Affordable ready-to-eat mycoprotein options appeal to mass consumers. Younger demographics are embracing sustainable diets. Asia Pacific will be the fastest-growing region globally.
Key players in the market
Some of the key players in Mycoprotein-Based Foods Market include Quorn Foods, Marlow Foods Ltd., Nestle S.A., Unilever plc, Tyson Foods, Inc., Maple Leaf Foods Inc., Archer Daniels Midland Company, Cargill, Incorporated, Ingredion Incorporated, Givaudan SA, Symrise AG, DuPont, Planted Foods AG, Meati Foods and Good Catch Foods.
In April 2026, Marlow Foods accelerated its strategic shift by supplying its "Marlow Ingredients" mycoprotein to major foodservice partners for a new range of 50/50 meat-mycoprotein hybrid products. This collaborative initiative is designed to reach "mainstream meat eaters" by blending fungal-derived protein with traditional meat to reduce environmental impact while maintaining familiar flavor profiles.
In January 2025, Cargill reported the successful scaling of its partnership with the food-tech firm ENOUGH to supply its high-fidelity "ABUNDA" mycoprotein to global consumer brands. This strategic collaboration leverages Cargill's massive logistics network to distribute fermented biomass as a primary ingredient for the next generation of whole-muscle chicken and seafood substitutes.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.